Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1CNS 1

Conditions

Pituitary Diseases 1Obesity 1Neoplasms 1Hypoglycemia 1Hyperinsulinism 1Gastro-enteropancreatic neuroendocrine tumor 1Craniopharyngioma 1

Interventions

Mifepristone 3Corlux 3Thyrotropin-Releasing Hormone 1Sodium Chloride 1Saline Solution 1Nivolumab 1LY2940680 1Ipilimumab 1Hydrocortisone 1Human Growth Hormone 1Diazoxide 1Dexmedetomidine 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pituitary Diseases × Diazoxide × Clear all
NCT00306683 2011-02-18

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
40 enrolled
CNSEndocrineOther

Craniopharyngioma, Hyperinsulinism, Neoplasms, Obesity, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡